Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7144877B2 · kind B2 · utility
18Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2001 |
| Grant date | Dec 5, 2006 |
| Priority date | — |
| Expiry date | Nov 30, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for providing enhanced systemic blood concentrations of orally delivered drugs that are incompletely translocated across the intestinal wall of an animal. Also disclosed are methods for the sustained release of drugs, whether poorly or readily bioavailable via oral delivery to animals. Still further, disclosed are compounds and pharmaceutical compositions that are used in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.